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Abstract Mesenchymal stem cells (MSC) are increasingly used as therapeutical aid for the
orthopaedic injuries in the horse. MSC populate different tissues but the most commonly
used for clinical purposes are isolated from bone marrow or adipose tissue. The first
objective of this study was to investigate if the donor animal, the tissue of origin and the
technique of isolation could influence the number of MSC available for transplantation after
a short-term expansion. The second aim was to devise a culture system capable of
increasing MSC lifespan and we tested the effect of basic fibroblast growth factor (bFGF).
Results indicate that MSC can be efficiently isolated from both sources and supplemen-
tation of bFGF enhances proliferation rate maintaining differentiation potential. In addition,
this study shows that collection, expansion and storage of frozen MSC can be performed for
later therapeutic use.
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Introduction
The isolation of mesenchymal stem cells (MSC) has been described in several species and from
different tissues, including bone marrow, peripheral blood, adult fat, umbilical cord blood and
skeletal muscle. The main feature of MSC is the ability to differentiate both in vitro and in vivo
along multiple pathways that include bone, cartilage, cardiac and skeletal muscle, tendon,
connective and adipose tissue. (Pittenger et al. 1999). For this reason MSC-based cell
therapies have been investigated for several years in human medicine and, more recently, the
same approach has been considered in equine veterinary medicine as a novel potential therapy
for horse musculoskeletal diseases (Frisbie 2005; Richardson et al. 2007; Smith et al. 2003).
In horses, mesenchymal stem cells from bone marrow have been isolated and
characterized by several authors (Arnhold et al. 2007; Koerner et al. 2006; Vidal et al.
2006) and their multilineage differentiation potential has been demonstrated by the ability
to undergo adipogenic, osteogenic and chondrogenic differentiation (Arnhold et al. 2007;
Fortier et al. 1998; Vidal et al. 2006).
Fibroblast-like precursor cells have been also isolated from equine umbilical cord blood
(Reed and Johnson 2008) and peripheral blood (Koerner et al. 2006), but in limited number
and contrasting findings have been reported on their differentiation potential. More
satisfactory results have been achieved with adult adipose tissue that has been proven a
reliable source of MSC capable to differentiate into several mesenchymal derivatives in
various species (Vidal et al. 2007; Zuk et al. 2002). Since these cells are readily accessible
in large quantity in the horse, they have received increasing attention for their possible
application for the treatment of musculoskeletal diseases. Recently, Vidal et al. have
reported data on cell-doubling characteristics and differentiation ability of equine adipose-
tissue derived stem cells in comparison to bone-marrow derived stem cells, showing that
both cell types can be expanded and are able to differentiate into mesenchymal derivatives
in vitro. Except for selected populations (Jiang et al. 2002), MSC are limited self-renewal
stem cells. Basic fibroblast growth factor (bFGF) is often supplemented to culture media for
several cell types to stimulate proliferation and for this reason it has been tested also on
human bone marrow stromal cells. Results indicate that bFGF enhances growth potential
during in vitro expansion (Bianchi et al. 2003) while maintaining their multidifferentiation
ability (Stewart et al. 2007) (Solchaga et al. 2005; Sotiropoulou et al. 2006). Therefore the
aim of this study has been to evaluate the proliferation potential of equine mesenchymal
stem cells, derived from adipose tissue and from bone marrow and cultured in presence of
basic fibroblast growth factor. In addition the data reported here provide quantitative practical
information on the possibility of storing MSC for future use for the treatment of horse tendon
injuries with autologous bone marrow or adipose tissue-derived mesenchymal stem cells.
Materials and methods
Unless otherwise indicated, chemicals were purchased from Sigma-Aldrich. Experimental
procedures on animals were carried out in accordance with DL 116/92 and were approved
by the Ministry of Health.
Bone marrow aspiration and isolation of bone marrow mesenchymal stem cells (BM-MSC)
Bone marrow was aspirated from the sternum and iliac crest of 4 horses, 2 to 4 years of age
using 11 g bone marrow biopsy/aspiration needles. After multiple PBS (Dulbecco’s
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phosphate buffered solution) washings the cell suspension was loaded onto a 70% Percoll
gradient and centrifuged at 1100 g for 30 min. Cells were collected from the interface and
washed. Following counting the cells were plated at 2×105 cells/cm2 and cultured in
DMEM-TCM199 (1:1) + 10% FBS (Gibco, Invitrogen, Milan, Italy). Medium was replaced
at 24 and 72 hours. After 1 week of culture the cell yield from different donor/sources was
evaluated. Part of the cells from first passages was frozen.
Adipose tissue collection and isolation of adipose tissue stem cells (AT-MSC)
Adipose tissues were collected from the supragluteal subcuteneous area of 15 horses
ranging from 2 to 9 years of age. Following several rinses in PBS the tissue was cut with a
sterile scissor and incubated for 1 h at 38°C in hepes-buffered medium supplemented with
1 mg/ml collagenase (Collagenase Type IV, Gibco, Milan, Italy). The digested tissue was
resuspended in serum containing medium and centrifuged. The remaining undigested tissue
was incubated for an additional hour with collagenase and subsequently centrifuged. Pellets
containing cells and tissue fragments were resuspended in culture medium (M199/DMEM
1:1 supplemented with 10% of FBS), washed once and plated in tissue culture 25 cm2
flasks. Yield of cells after 1 week of culture was recorded. Part of the cells from the first
passages was frozen.
Undifferentiated cell culture and population doublings
Sternal BM-MSC from donor n°13 and n°15 and AT-MSC from donor n°3 and n°15 were
plated at a density of 5 X 103 cells/cm2. Control cultures were maintained in medium
TCM199/DMEM (1:1) supplemented with 10% fetal bovine serum (FBS), at 38.5°C in 5%
O2. Treated cultures were grown in the same conditions in presence of human bFGF
(Peprotech, London, UK) at a final concentration of 5 ng/ml. Cells were cultured until they
reached 80–90% confluence. Subsequently, cells were trypsinised, counted for the
population doublings determination and reseeded at a density of 5×103 cells/cm2. This
procedure was repeated up to about 4 months of culture. Cell aliquots from different
passages were used for in vitro differentiation as subsequently described.
Osteogenic differentiation
Equine AT-MSC and BM-MSC from different passages of the four lines used were plated at
3×103 cells/cm2 in culture medium for 24 hours. Then the medium was replaced with
osteogenic medium containing dexamethasone 100 nM, ascorbic acid 0.25 mM and β-
glycerolphosphate 10 mM. After 8–12 days of culture, the cells were stained to reveal
alkaline phosphatase activity (BCIP/NBT, Lab Vision Corp., Fremont, CA). Calcium
accumulation was detected by Von Kossa staining after 21 days of culture. Alkaline
Phosphatase and Von Kossa staining were performed on undifferentiated AT-MSC and BM-
MSC cultured in non-inductive medium to detect the endogenous activity. Additionally,
equine adult fibroblasts were cultured in the same culture conditions as negative controls.
Chondrogenic differentiation
Chondrogenic differentiation was performed in pellet culture on different passages of
equine AT-MSC and BM-MSC from donor n°15. Approximately 5×105 cells were
suspended in 2 ml of chondrogenic medium, containing dexamethasone 100 nM, ascorbic
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acid 0.25 mM, 5 ng/ml of TGFβ1 (Peprotech, London, UK) and ITS (ITS premix, VWR
International, Milan, Italy) placed in a 10 ml-tube, centrifuged at 500 rpm for 7 minutes and
incubated at 38.5°C in 5% O2. After 3 weeks, cells were stained with Alcian Blue to detect
glycosamminoglicans content.
Occasionally chondrogenic differentiation was performed in monolayer under the same
culture conditions. Alcian Blue staining was performed also on AT-MSC and BM-MSC
cultured in non-inductive medium to detect a basal signal. Additionally, equine adult
fibroblasts were cultured in the same conditions as a negative control.
RNA extraction and semi-quantitative gene expression analysis
Total RNA was extracted with RNeasy Mini Kit (Qiagen, Hilden, Germany) from samples
of undifferentiated and differentiated cells. The RT reaction was performed using a First
strand cDNA synthesis kit (Fermentas, Ontario, Canada) according to the instructions of the
manufacturer. PCR reaction was performed using an MJ Minicycler and Hot StarTaq
Polymerase (Qiagen, Hilden, Germany). After RT-PCR reaction electrophoresis was
performed on a 2.5% agarose gel. The results of the electrophoresis were captured with a
Gel Logic 100 Kodak Imaging System and images were analysed with a Kodak Molecular
Imaging Software. The intensity of each band was analysed by densitometry and the results
were normalised using 18 S as external standard. The following primers were used
(Giovannini et al. 2008): 18 S: FW 5′CGGCTACCACATCCAAGGAA 3′, RV 5′
GCTGGAATTACCGCGGCT 3′ ; Aggrecan: FW 5′ ACAACAATGCCCAAGACTAC 3′,
RV 5′ GCCAGTTGTCAAATTGCAAG 3′; Collagen Type II: FW 5′ TGAAACTCTGC
CACCCTGAATG 3′, RV 5′ TTGTCCTTGCTCTTGCTGCTC 3′; Osteonectin: FW 5′
AGACCTTCGATTCCTCCTGC 3′, RV 5′ TTGCCCTCATCCCTTTCG 3′. Osteonectin
sequence was identified in equus caballus genome (XM001503651) by homology (93.8%)
with human sequence (NM_003118). Primers for osteonectin were designed using the
software VectorNTI 10 Advance and PCR product was sequenced obtaining an identity
score of 94.6%.
Statistical analysis
Statistical analysis was done performing Student T test. Values were considered statistically
different when P was<0.05.
Results
Isolation and expansion of equine AT-MSC and BM-MSC and cell doubling data
Cell yields obtained after 1 week of culture from different donors and sources are listed in
Tables 1 and 2.
In Table 1 are shown the data referring to the efficiency of isolation of MSC from
adipose tissue from 11 horses and the corresponding cell yield obtained after one week
from the initial plating. Similarly in Table 2 are shown the data referring to MSC collection
from 4 additional donors and from different sources: adipose tissue, sternum and iliac crest.
The data reported in Table 1 indicate that after one week of expansion the yield of MSC
varies from 5×105 to 5×106 and this number is not always related to the amount of starting
tissue: for instance 12 g of adipose tissue from donor 4 provided 5×105 cells after one week
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while 11 g from donor 1 provided 4×106 cells in the same culture time. Comparing the data
reported in Table 1 with those of Table 2 it is clear that the amount of starting tissue is much
higher in the second group of animals most likely due to the different operators who
performed the sampling. Interestingly, the number of cells per gram of tissue obtained after
one-week expansion from group 1 (average 209,000 cells/gram) is significantly higher (T
Student test. P<0.05) than the average obtained from group 2 (108,000 cells/gram). This
indicates that the digestion of the adipose tissue has been relatively inefficient from the
second group of animals suggesting that the digestion procedure must be adapted (higher
enzyme concentration/longer exposure) to the amount of tissue to be processed in order to
optimise results, also if we cannot exclude an intrinsic variability between samples. We also
found a significant (T test, p=0.03) lower yield of cells for gram of tissue from the samples
of the two older horses (donor number 2 and 4), however due to the low number of horses
in this group data need to be further confirmed.
All cultured cells showed fibroblastic morphology (Fig. 1a) and the supplementation of
bFGF induced a slight change towards a more spindle shaped morphology (Fig. 1b).
Table 1 Isolation of MSC from adipose tissue of different donors
Donor Age Quantity of tissue (gr) Yield after 1 week Cells/gr
1 4 11 4000000 363636
2 8 5 800000 160000
3 2 11 1600000 145455
4 9 12 500000 41667
5 4 12 2000000 166667
6 4 19 4000000 210526
7 4 19 4000000 210526
8 2 10 2800000 280000
9 4 19 5200000 273684
10 2 22 5000000 227273
11 2 18 4000000 222222
Table 2 Isolation and yield of MSC from different sources
Donor Age Type of tissue Quantity of tissue Yield after 1 week Cells/Tissue
12 2 Adipose tissue 50 gr 6000000 120000
Sternal bone marrow 100 ml 8000000 80000
Iliac crest bone marrow 50 ml 3000000 60000
13 2 Adipose tissue 40 gr 5000000 125000
Sternal bone marrow 50 ml 6000000 120000
Iliac crest bone marrow 80 ml 5000000 625000
14 2 Adipose tissue 57 gr 5000000 87719
Sternal bone marrow 55 ml 6000000 109090
Iliac crest bone marrow 75 ml 6000000 80000
15 4 Adipose tissue 61 gr 6000000 98360
Sternal bone marrow 120 ml 6000000 50000
Iliac crest bone marrow 75 ml 5000000 66666
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Growth characteristics of equine BM-MSC and AT-MSC are summarized in Table 3 and
Fig. 2. The data indicate, under our experimental conditions, a higher proliferation potential
of AT-MSC as compared to BM-MSC, proliferation that was further enhanced by bFGF
supplementation.
In this study we have cultured 2 lines of equine AT-MSC and 2 lines of equine AT-MSC
up to 90-120 days to evaluate proliferation rate and doubling time (see Table 3). Our data
indicate that the AT-MSC lines have a higher proliferative ability (population doublings) as
compared to the BM-MSC lines although not statistically different (T test, p=0.12).
Moreover, we found that the supplementation of bFGF considerably increased proliferation
rate of both BM-MSC and AT-MSC lines with statistically significant effect for AT-MSC (T
Fig. 1 a-b: Undifferentiated adipose tissue-derived mesenchymal stem cells untreated (a) and treated with
bFGF (b). c-d: Osteogenic differentiation: alkaline phosphatase detection after 10 days in osteogenic medium
(c) and von kossa staining after 21 days of culture (d). e-f: Chondrogenic differentiation: alcian blue staining
of cells treated for 21 days with chondrogenic medium in monolayer (e) or in pellet (f)
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test, p=0.015) and value near the significant level for BM-MSC (T test, p=0.075). In order
to provide an estimate of the number of cells that can be obtained from the different sources
with or without bFGF supplementation during culture, we have calculated (Table 3) the cell
yield after three and six weeks expansion. Interestingly, referring to donor 15, the data on
cell number after one week of culture (Table 2) indicate an equal number of cells obtained
from adipose tissue and from sternal bone marrow. However, the cell yield after three
weeks is over ten times higher for AT-MSC than for BM-MSC. The supplementation with
bFGF amplifies this difference by a factor of three and comparing mean proliferation ability
for the two donors in presence of FGF the difference between sources was statistically
significant (T test, p=0.01). Considering the cell yield after six weeks of culture both the
source of cells and the supplementation of bFGF further increase the differences observed
above. Similar data have been obtained with AT-MSC derived from donor 3 and BM-MSC
obtained from donor 13.
Table 3 Cell growth characteristics of equine AT and BM-MSC cultured in control conditions and treated





Yield after 3 weeks
from isolation
Yield after 6 weeks
from isolation
AT-MSC
Donor 3 92 36.5 (2.5) 144×106 45.6×109
Donor 15 122 28.9 (4.2) 348×106 10.7×109
AT-MSC(+)FGF**
Donor 3 95 67.7 (1.4) 6.5×109 17×1014
Donor 15 112 64.6 (1.7) 393×109 415×1014
BM-MSC
Donor 13 100 13.3 (7.5) 89×106 2.7×109
Donor 15 118 22.1 (5.3) 34×106 623×106
BM-MSC(+)FGF**
Donor 13 85 32.6 (2.6) 2.9×109 25×1012
Donor 15 112 37.9 (2.9) 11.5×109 25×1012
*Population doublings and doubling time are calculated starting from week 1 after isolation
** FGF treatment has been started 1 week after isolation. See Table 1
Fig. 2 Representative growth
curves of the lines derived from
adipose tissue and bone marrow
of donor n°15 grown in control
medium or in presence of bFGF
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Culture differentiation
Following induction of osteogenic differentiation we observed a clear change of
morphology in all cell lines tested. Cells acquired a polygonal shape within three days
and cell-aggregates and nodule formation were observed after 4–6 days of culture. Alkaline
phosphatase activity (Fig. 1c) was increased in comparison to endogenous basal activity
and matrix mineralization and calcium accumulation were detected by Von Kossa staining
after 21 days of culture (Fig. 1d).
Both AT-MSC and BM-MSC cultured with bFGF supplementation displayed similar
morphological changes after exposure to osteogenic medium and qualitative macroscopical
observation performed by different operators showed that alkaline phosphatase activity was
increased in comparison to control cultures. As previously observed, calcification appeared
as several black regions within the cell monolayer. When the differentiation potential of
equine mesenchymal stem cells was compared to equine adult fibroblasts, we found that
fibroblast cells did not respond to osteogenic induction. Only sporadic cells were positive
for alkaline phosphatase, whereas calcium accumulation was undetectable, suggesting an
undifferentiated phenotype, although the cells did not appear healthy and extensive cell
death was observed in these culture conditions.
All cell lines underwent chondrogenic differentiation at much higher level in pellet
culture (Fig. 1f) as compared to monolayer culture (Fig. 1e), with no significant decrease
with increasing population doublings.
The expression data from RT-PCR analysis are illustrated in Fig. 3 and indicated the
presence of a basal expression of osteonectin and aggrecan in undifferentiated MSC that
increased after treatment with osteogenic and condrogenic medium respectively. By contrast,
the condrogenic marker collagen II was expressed in chondro-differentiated cultures while
was undetected in undifferentiated MSC. Treatment with FGF increased the expression of
osteonectin both in undifferentiated and differentiated cells but not at statistically significant
level (T test, p=0.2 and p=0.09 for undifferentiated and differentiated cells respectively)
Discussion
In this study, we compared equine MSC from bone marrow and adipose tissue for growth rate,
differentiation ability and influence of bFGF on these features. We observed differences in cells
yield from different donors especially following isolation from adipose tissue. This finding
indicates not only donor specific differences but also that digestion procedure must be adapted
to the amount of tissue as we found in more recent experiments (personal observation). We
evaluated 4 cell lines of equine BM-MSC and AT-MSC, and we found relevant differences in
cell growth characteristics. All theMSC lines maintained their differentiation ability throughout
the culture period although a progressive reduction in the efficiency of differentiation was
observed in the last passages. This reduction is likely the consequence of cell senescence that
was morphologically evident also in the late passages of the undifferentiated cultures. Similar
differences in growth potential of mesenchymal stem cells are reported for human MSC: while
some cell lines can be expanded for more than 15 cell doublings, for others proliferation is
limited to 4 cell doublings (Bruder et al. 1997; Digirolamo et al. 1999). Critical parameters for
MSC isolation include donor variability, tissue of origin, cell selection and enrichment,
culture surface coating, culture media, oxygen tension, serum supplements, cell density of
culture, which all can have impact on morphology and composition of cell preparations
(Sotiropoulou et al. 2006; Wagner and Ho 2007). Based on our results, mesenchymal cells
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from adipose tissue are superior to BM-MSC regarding proliferating ability both for total
number and doubling time, even considering that the starting number of AT-MSC was lower
than BM-MSC. Similar finding have been previously described (Izadpanah et al. 2006; Kern
et al. 2006; Lee et al. 2004) although other authors did not find any significant differences
among MSC from different sources (De Ugarte et al. 2003).
To test the effect of bFGF on equine MSC, we compared growth rate and population
doublings of cells cultured in control medium and in medium supplemented with bFGF. We
Fig. 3 a: Relative expression of
osteonectin in AT-MSC(+/-fgf)
and BM-MSC (+/-fgf) undiffer-
entiated and differentiated for
1 week in osteogenic medium.
b-c: Relative expression of colla-
gen type II and Aggrecan in AT-
MSC (+/-fgf) (b) and BM-MSC
(+/-fgf) (c) differentiated in con-
drogenic medium for 10 days
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found that the addition of bFGF increased growth rate and population doublings of equine
MSC irrespective of tissue of origin as previously found in other species (Bianchi et al. 2003;
Ito et al. 2007; Solchaga et al. 2005; Sotiropoulou et al. 2006; van den Bos et al. 1997).
Moreover, in agreement with our findings, previous reports on various species showed that
bFGF treatment could increase differentiation ability of MSC in vitro (Stewart et al. 2007)
(Hanada et al. 1997; Sotiropoulou et al. 2006) and bone synthesis in in vivo models by
stimulating osteoprogenitor cells (Amizuka et al. 1998). We also found that bFGF treatment
had a tendency, also if not statistically significant, to increase osteonectin mRNA
expression level both in AT and BM-MSC when cultured in osteogenic induction medium.
Finally, the long-term cultures performed in this study demonstrated that MSC from all
the three donors examined and especially if supplemented with bFGF, represent a large
reservoir of cells for potential clinical use. In this study we consider for long-term analysis
4 out of 23 lines derived and also if large variability between donors was observed, we were
able to conclude that in the context examined, the collection, expansion and storage of
frozen MSC, can be proposed as a preventive strategy for those valuable sporting horses
that are most exposed to the risk of ligament and skeletal injuries. In this way autologous
MSC, available in large quantities, just after thawing and short overnight culture, could
represent a ready-to-use therapeutic option/aid for orthopaedic diseases. In conclusion, we
demonstrated, although in a limited number of donors, that equine AT-MSC are a better
source of progenitor cells regarding growth rate and population doubling number than BM-
MSC, and have a greater response to the addition of bFGF in culture medium. Moreover,
we showed that after bFGF treatment, MSC retain the ability to differentiate into osteogenic
and chondrogenic lineages, a finding that could have important implications in veterinary
tissue engineering and regenerative therapies. Controlled clinical studies are the next step
required to fully evaluate the effects of bFGF supplementation during culture on the
therapeutic potential of MSC for the treatment of equine orthopaedic injuries.
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